Skip to main content
. 2022 Sep 6;23(18):10223. doi: 10.3390/ijms231810223
AD Alzheimer’s disease
AEP asparaginyl endopeptidase
LGMN legumain
APP amyloid precursor proteins
amyloid-β protein
Asn asparagine
Asp asparate
TLRs toll-like receptors
APCs Ag-presenting cells
ER endoplasmic reticulum
LSAM Legumain stabilization and activity modulation
MBP myelin basic protein
PD Parkinson’s disease
VD vascular dementia (VD)
FTLD frontotemporal lobar degeneration (FTLD)
DLB dementia with Lewy bodies
APOE4 apolipoprotein E4
NFTs neurofibrillary tangles
SET an inhibitor of protein phosphatase 2A
PP2A protein phosphatase 2A
C/EBPβ CCAAT/enhancer binding protein β
FSH follicle-stimulating hormone
MCI mild cognitive impairment
CSF cerebrospinal fluid
P-tau phosphorylated tau
PET positron-emission tomography
BBB blood–brain barrier
AuNPs gold nanoparticles
CT computerized tomography
MRI magnetic resonance imaging
TBI traumatic brain injury
tMCAO transient occlusion of the middle cerebral artery
OGD the oxygen–glucose deprivation
Ca2+ calcium
TDP-43 TAR DNA-binding protein 43
GBM glioblastoma